Overview
What is John Paul Ii Medical Research Institute?
The John Paul II Medical Research Institute, located in Coralville, Iowa, is a nonprofit organization dedicated to advancing medical research. Its mission is to recognize and uphold the dignity of human life from conception to natural death, while addressing unmet medical needs. The institute specifically focuses on developing cures and therapies using adult stem cells and induced pluripotent stem cells, without engaging in embryonic stem cell research. In 2022, the institute continued its efforts in creating a safer and more robust coronavirus vaccine using a traditional non-mRNA-based approach, ensuring it was free of aborted fetal tissue. The institute collaborates with other organizations for validation and refines its vaccine development efforts to address the need for an ethically developed vaccine. With a team of 7 employees, the John Paul II Medical Research Institute strives to advance drug discovery and regenerative medicine for various diseases while promoting educational outreach in medical bioethics.
Official website here: www.jp2mri.org
Is John Paul Ii Medical Research Institute legitimate?
John Paul Ii Medical Research Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. John Paul Ii Medical Research Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $111,523
Professional Fundraising Fees: $0
Other Salaries and Wages: $38,963
For more financial information, click here
Official website here: www.jp2mri.org
What is the mission statement of John Paul Ii Medical Research Institute?
The John Paul II Medical Research Institute advocates for medical research that acknowledges the dignity of human life from conception to natural death and addresses unmet medical needs. Its mission is to find cures and therapies exclusively using a variety of adult stem cells and induced pluripotent stem cells. The institute does not engage in embryonic stem cell research of any kind. In addition to conducting preclinical research technologies that will broadly advance drug discovery and regenerative medicine for numerous diseases, the institute also focuses on educational outreach to increase the number of scientists and future medical practitioners working with adult stem cells. This educational initiative emphasizes medical bioethics, consistently upholding the dignity of human life.
Official website here: www.jp2mri.org
Who is the CEO of John Paul Ii Medical Research Institute?
Jay Kamath is the President of John Paul Ii Medical Research Institute.
Official website here: www.jp2mri.org
What is the revenue of John Paul Ii Medical Research Institute?
John Paul Ii Medical Research Institute's revenue in 2022 was $469,748.
Official website here: www.jp2mri.org
Who are the executives of John Paul Ii Medical Research Institute and what are their salaries?
The average compensation at John Paul Ii Medical Research Institute during 2022 was $21,498. There are 7 employees and 6 volunteers at John Paul Ii Medical Research Institute.
Here are 6 key members and their salaries:
- Jay Kamath (President) [Trustee/Director]
- Dr Alan Moy (Vice President) [Trustee/Director]
- Jeanne Moy (Director)
- Isaac Doucette (Director)
- Dr James Becker (Director)
- Dr Martin Bednar (Director)
Official website here: www.jp2mri.org
Where can I find the form 990 for John Paul Ii Medical Research Institute?
The John Paul Ii Medical Research Institute’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.jp2mri.org
Learn more at the official website: www.jp2mri.org
Mission Statement of John Paul Ii Medical Research Institute
The John Paul II Medical Research Institute is committed to advocating for medical research that recognizes the inherent dignity of human life from conception to natural death. The institute aims to address unmet medical needs by leveraging a variety of adult stem cells and induced pluripotent stem cells. The John Paul II Medical Research Institute does not engage in embryonic stem cell research of any kind. Instead, it focuses on developing preclinical research technologies that can significantly advance drug discovery and regenerative medicine for numerous diseases. Additionally, the institute is dedicated to educational outreach, with the goal of increasing the number of scientists and future medical practitioners who work with adult stem cells, always emphasizing medical ethics that uphold the dignity of human life.
Impact
This information is meant to be a general summary of John Paul Ii Medical Research Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Wednesday, July 24, 2024
John Paul II Medical Research Institute advocates for medical research that recognizes the dignity of human life from the moment of conception to natural death and addresses unmet medical needs. The institute's impact lies in its commitment to developing a collaborative basic and clinical research program in core areas such as cancer, neurodegenerative diseases, rare diseases, and adult stem cell therapies. Notably, in 2022, JP2MRI advanced its research efforts by focusing on developing a safer and more robust coronavirus vaccine using a traditional non-mRNA-based approach that is free of aborted fetal tissue in development and testing.
Through its innovative work, the institute is contributing to the development of potential vaccine candidates, which were sent to the University of Iowa for validation. JP2MRI's dedication to refining vaccine development efforts underscores its mission to address the need for a better ethically developed vaccine. By exclusively utilizing a variety of adult stem cells and induced pluripotent stem cells, the institute is focused on finding cures and therapies while abstaining from engaging in embryonic stem cell research.
Moreover, JP2MRI's commitment extends to developing preclinical research technologies that advance drug discovery and regenerative medicine for various diseases. The institute's emphasis on educational outreach further contributes to increasing the number of scientists and future medical practitioners who will work with adult stem cells while upholding medical bioethics consistent with the dignity of human life. JP2MRI's impact in the field of medical research is significant, underscoring its dedication to advancing scientific solutions ethically and responsibly.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
OTHER INCOME
Revenue
$4,953
Organization Details
Founding Year
2006
Phone
(319) 688-7367
Principal Officer
Jay Kamath
Main Address
2500 CROSSPARK RD E108, CORALVILLE, IA, 52241
Website
www.jp2mri.org
NTEE Category
Code: H99 - Medical research
If you are a representative of John Paul Ii Medical Research Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.